Tai 2002.

Methods	Randomised, double‐blind, placebo‐controlled, cross‐over, no enrichment. No imputation method mentioned Titration to limit of tolerability or maximum 1800 mg over 3 weeks, then stable for remainder of 4‐week period; 2‐week washout then cross‐over
Participants	Traumatic spinal cord injury > 30 days. PI before treatment > 4/10 N = 14 (7 participants with data) Age 27‐48 years, 1/7 women
Interventions	Gabapentin 1800 mg daily (max) Placebo NSAID, TCA and narcotics allowed for rescue medication as needed
Outcomes	Withdrawals
Notes	Oxford Quality Score: R = 2, DB = 2, W = 1, Total = 5 Grants from American Academy of Physical Medicine and Rehabilitation and Eastern Paralyzed Veterans Association
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	Random distribution table
Allocation concealment (selection bias)	Unclear risk	Not reported
Blinding (performance bias and detection bias) All outcomes	Low risk	Capsules with "identical shape and colour"
Incomplete outcome data (attrition bias) Efficacy	Unclear risk	Imputation not mentioned
Size Efficacy	High risk	< 50 participants per treatment arm (7/14 with data)